Quality of life is an important area of clinical neurooncology that is increasingly relevant as
survivorship increases and as patients experience potential morbidities associated with new …

In adults, primary malignant brain tumors (PMBT) are rare, but they have a devastating
impact and the chances for survival are limited. UK clinical guidance on supportive care for …

Background Standard therapy for newly diagnosed glioblastoma is radiotherapy plus
temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab …

Purpose Patients with gliomas often experience cognitive deficits, including problems with
attention and memory. This randomized, controlled trial evaluated the effects of a …

Background Depression is a common and important complication of primary cerebral
glioma. However, observational studies of this relationship have not been systematically …

Health-related quality of life (HRQOL) has become an important outcome measure in clinical
trials in primary brain tumor (ie, glioma) patients, because they have an incurable disease …

The maintenance of quality of life (QoL) in patients with high-grade glioma is an important
endpoint during treatment, particularly in those with glioblastoma multiforme (GBM) given its …

Mitchell AJ, Kemp S, Benito-León J, Reuber M. The influence of cognitive impairment on
health-related quality of life in neurological disease. Background: Cognitive impairment is …

OBJECTIVE: This study assessed the quality of life and psychosocial well-being of brain
tumor patients and their carers. METHODS: A cross-sectional postal survey was completed …

Background The median survival of glioblastoma is 12–14 months with less than 10% of
patients surviving at least 2 years from diagnosis. Patients diagnosed with glioblastoma face …